Our latest review article in Clinical Cancer Research online ahead of print ➡️ New means and challenges in the targeting of BTK! 🙌 Check it out to get an update on #CLLsm #lymsm #leusm new drugs targeting BTK and new biology of BTKi resistance! #PrecisionOncology aacrjournals.org/clincancerres/…

How many functional clusters of monocytes are there? How do they impact #CART in #lymsm ? Visit Andre Corraes poster today eppro01.ativ.me/appinfo.php?pa… #AACR24 Haidong Dong Mayo Clinic Comprehensive Cancer Center

Details to access LU by Dr. W. Wang+@gontaMD on 4-12-24 at 4:00PM CT
📢Meeting: bit.ly/3Jgf8pc
ID: 840 4024 2833 code: 898162
Slides: bit.ly/3VJdy6w
#hemepath #pathedu #pathtwitter #lymsm
@kirillLyapichev Siba El Hussein, MD Do Kim, M.D.

With the new MZL-IPI the concept of disseminated MZL is defined and is associated with worst outcomes. Learn how to define a disseminated MZL 👇 #lymsm Luca Arcaini Côme Bommier Juan P. Alderuccio Matthew J. Maurer, DMSc FIL_ETS

My amazing mentor, Dr Francine Foss, presenting data for metanalysis evaluating alloSCT in MF/SS Yale Cancer Center YaleHematology #5WCCL #lymsm City of Hope CME

NEW: Anti-CD30 CAR T-cell infusion as consolidation after BEAM and autologous HSCT is safe, and showed preliminary activity in patients with Hodgkin lymphoma at high risk of relapse (trial included also patients with documented CD30+ NHL) #lymsm

thelancet.com/journals/lanha…

Follicular lymphoma!
Diagnosis, treatment, mutation testing and more..
#hemepath
#lymsm
Loretta J. Nastoupil, MD

Details to access BMU by Dr. Lin+Xenia Parisi, MD @9:15 AM CT tmrw
📢Meeting: bit.ly/49uxhtS
ID: 870 8831 3485 code: 121938
Slides: bit.ly/4cJMQRr
#hemepath #pathedu #pathtwitter #lymsm
@kirillLyapichev Siba El Hussein, MD

Tune in for CLL/SLL diagnosis, prognosis, and treatment.
#hemepath #lymsm
Thanks Matthew Davids, MD, MMSc

#Hematology Prevention and treatment of #infection in patients with an absent or hypofunctional spleen: A British Society for Haematology ⁦BSH - Haematology⁩ guideline #lymsm #vaccination #splenectomy onlinelibrary.wiley.com/doi/10.1111/bj…

#Hematology Metabolic rewiring promotes anti-inflammatory effects of #glucocorticoids | ⁦nature⁩ #lymsm #mmsm nature.com/articles/s4158…

#Hematology Hematological Complications of Human Immunodeficiency Virus ( #HIV ) Infection: An Update From an HIV-Endemic Setting #lymsm academic.oup.com/ofid/article/1…

#Hematology B-cell non-Hodgkin #lymphoma #NHL - ⁦The Lancet⁩ #lymsm thelancet.com/journals/lance…

B-Cell Non-Hodgkin Lymphoma: Extended Follow-up With Mosunetuzumab ascopost.com/news/april-202… #lymsm #lymphoma #immunotherapy #oncology

March Approval Madness: OncLive’s Roundup of U.S. FDA Decisions in Oncology #lcsm #leusm #lymsm #blcsm #gyncsm onclive.com/view/march-app…

ICYMI: first-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin achieves a complete response of 85% (29 of 34) in patients w/ advanced extranodal natural killer/T cell lymphoma. Results of the ph2 SPIRIT trial #lymsm thelancet.com/journals/lanha…

Have you completed the Global Patient Survey on Lymphoma & CLL yet? Add your voice now. bit.ly/LCGPS2024

#lymphoma #CLL #lymsm #CLL sm

👉👉👉Absolute all-time multi-disciplinary #HemeDreamTeam !!! 👏 Major shout out to Dr .Sanam Loghavi, MD صنم لغوی 🔬🧬 & Dr .Chelsea C Pinnix MD PhD w/Prof Pemm Naveen Pemmaraju, MD || #leusm #BPDCN #lymsm #MPNSM || #endcancer MD Anderson Cancer Center

Explore our new case studies on VJHemOnc! 🤩

In this FL case study, learn directly from Sanam Loghavi, MD صنم لغوی 🔬🧬 & Loretta J. Nastoupil, MD as they discuss diagnosis, disease classification, the relevance of mutation testing for patients with FL & more!

👉 ow.ly/SAj450R89nk

#LymSM

📣Last call: Lymphoma Coalition’s 9th Global Patient Survey on Lymphoma & CLL closes today. Patients and caregivers – take the time to share your experience now and make a difference in #lymphoma #CLL care worldwide. #lymsm bit.ly/LCGPS2024